Skip to main content
. 2016 Oct 1;6(10):2323–2333.

Figure 2.

Figure 2

Prognostic significance of DUSP5 in CRC patients. A: CRC-specific survival and Disease-free survival (DFS) curves of the whole study cohort. B: CRC-specific survival and DFS curves of low-risk stage II patients receiving no chemotherapy. C: CRC-specific survival and DFS curves of high-risk stage II patients receiving FOLFOX scheme. D: CRC-specific survival and DFS curves of stage III patients receiving FOLFOX scheme. E: CRC-specific survival and DFS curves of stage IV patients receiving FOLFOX scheme.